As the compendium of putatively disease causing variants expands, gathering the most current and accurate information is critical to computing variant classifications. The QIAGEN knowledgebase includes the most extensively curated database of variant specific publications, including functional studies and clinical cases. QIAGEN Clinical Insight (QCI) leverages this information to invoke all ACMG rules to automatically compute variant classifications. In this webinar, you will see how QCI classifies over 6,000 ClinVar expert panel assessed BRCA1 and BRCA2 variants with incredible accuracy. With respect to clinical actionability, QCI automated ACMG classification was 99.6% concordant with ENIGMA expert panel variant assessments. This level of accuracy speaks to the quality of the clinical, functional, and population level data in the knowledgebase, as well as the robustness of the underlying algorithm used to apply the ACMG guidelines.
Cancer Research
Personalized Medicine
Dna Sequencing
Immunity
Clinical Diagnostics
Biotechnology
Immunotherapy
Antibodies
Flow Cytometry
Research
Immuno-Oncology
Cancer Therapeutics
Gene Expression
Big Data
Dna
North America33%
Asia33%
Europe33%
Website Visitors100%
Student33%
Facility/Department Manager33%
Medical Laboratory Technician33%
Life Science Company33%
Manufacturer - Other33%
Academic Institution33%